发明名称 |
Inhibitors and methods of inhibiting bacterial and viral pathogens |
摘要 |
Compounds, pharmaceutical compositions and methods for treating viral and bacterial infections, by administering certain thiourea compounds, specifically acylthiourea, carboximidoylthiourea and S-alkyl isothiourea derivatives and analogs, in therapeutically effective amounts are disclosed. |
申请公布号 |
US9233087(B2) |
申请公布日期 |
2016.01.12 |
申请号 |
US201113578413 |
申请日期 |
2011.02.18 |
申请人 |
SIGA TECHNOLOGIES, INC |
发明人 |
Allen Robert D.;Amberg Sean M.;Dai Dongcheng;Burgeson James R.;Hruby Dennis E. |
分类号 |
C07C335/26;C07C335/20;C07C335/38;C07D213/81;C07D213/82;A61K31/17;A61K45/06;C07D495/04;A61K31/4409 |
主分类号 |
C07C335/26 |
代理机构 |
Ostrolenk Faber LLP |
代理人 |
Achkar Charles C.;Ostrolenk Faber LLP |
主权项 |
1. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound having the following general Formula II or a pharmaceutically acceptable salt thereof: wherein X is selected from the group consisting of oxygen and NH; Y is selected from the group consisting of: —CH2—, —C(═O)—, —C(═S)— and —C(═NH)—; A is selected from the group consisting of: N and CR5; B is selected from the group consisting of: N and CR6; R1 is selected from the group consisting of: hydrogen and ethyl; R2 is selected from the group consisting of: hydrogen and chloro; R3 is selected from the group consisting of: hydrogen, methoxy, amino and hydroxyl; R4 is selected from the group consisting of: hydrogen, chloro and amino; R5 is selected from the group consisting of hydrogen and aminomethyl; and R6 is selected from the group consisting of hydrogen, amino and aminomethyl and wherein R3 and R4 cannot both be hydrogen. |
地址 |
Corvallis OR US |